[Network Meta-analysis of Chinese patent medicine containing Hirudo in treatment of atherosclerosis].

Han, Qian-Qian; Wen, Zi-Yun; Lyu, Qing; Pan, Yun-Yun

Han, Qian-Qian; Wen, Zi-Yun; Lyu, Qing; Pan, Yun-Yun.

Afiliação

Han QQ; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University Guangzhou 510515, China the First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, China.
Wen ZY; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University Guangzhou 510515, China the First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, China.
Lyu Q; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University Guangzhou 510515, China the First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, China.
Pan YY; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University Guangzhou 510515, China.

Zhongguo Zhong Yao Za Zhi ; 48(1): 234-246, 2023 Jan.

Article em Zh | MEDLINE | ID: mdl-36725276

Assuntos

Aterosclerose; Medicamentos de Ervas Chinesas; Inibidores de Hidroximetilglutaril-CoA Redutases; Humanos; Metanálise em Rede; Medicamentos sem Prescrição/uso terapêutico; Cápsulas; Teorema de Bayes; Espessura Intima-Media Carotídea; Medicamentos de Ervas Chinesas/uso terapêutico; Aterosclerose/tratamento farmacológico; Medicina Tradicional Chinesa

Palavras-chave

Bayesian model; Chinese patent medicine; Hirudo; atherosclerosis; network Meta-analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google